长期家庭氧疗对慢性阻塞性肺病患者临床和生活质量的影响被引量：2

下载PDF

导出

摘要目的:探讨长期家庭氧疗(LT-DOT)对慢性阻塞性肺病缓解期患者临床和生活质量的影响。方法:57例COPD缓解期患者,分为两组,氧疗组30例,对照组27例,两组均实施常规治疗,同时氧疗组实施LTDOT,对照组未行LTDOT治疗,治疗2年后分别观察治疗前后血常规、血黏度、指脉血氧饱和度以及呼吸困难指数和生活质量评分(SGRQ)。结果:氧疗组呼吸困难改善总有率为90%,对照组为44.4%。SGRQ评分氧疗组治疗前后差异均有显著性(P<0.05,P<0.01),对照组在活动能力和对日常生活影响方面治疗前后差异无显著性(P>0.05),两组疗效比较差异有显著性(P<0.05)。氧疗组治疗前后血红细胞计数、血红蛋白、红细胞压积以及血氧饱和度差异均有显著性(P<0.05),而对照组治疗前后比较差异无统计学意义;氧疗组治疗后血黏度明显降低,治疗前后比较有显著性变化(P<0.05),对照组治疗前后差异无显著性(P>0.05)。结论:COPD缓解期患者予以LTDOT治疗,疗效肯定,值得推广应用。

作者张晓燕赵月霞

机构地区宁夏自治区银川消防支队卫生所宁夏医科大学附属医院

出处《中国社区医师（医学专业）》 2011年第18期72-73,共2页

关键词慢性阻塞性肺病(COPD) 长期家庭氧疗(LTDOT) 缓解期生活质量评分

分类号 R563.1 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献8

1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量：8232
2Crockett AJ, Cranston JM, Moss JK, et al. A review of long - term oxygen therapy for chron- ic obstructive pulmonary disease [ J ]. Respir Med,2001,95 (6) :437 - 443.
3Alfrd PF, Jack AE, Jay AF, et al. Fishman s pulmonary disease and disorders [ J ]. Graw Hill Companies, 1998,1 (3) :372.
4Petty TL. Home oxygen therapy - a revolution in the care of advanced COPD[J]. Med Chn North Am, 1990,74:715 - 729.
5Hanania NA, Ambrosino N, Calverley P, et al. Treatments for COPD [ J ]. Respir Med, 2005, 99( Suppl B) :28 -40.
6柳涛,蔡柏蔷.慢性阻塞性肺疾病患者生活质量评估方法及其意义[J].中国呼吸与危重监护杂志,2003,2(4):196-197. 被引量：54
7Domingo - Salvany A, Lamarca R, Ferrer M, et al. Health - related quality of life and mortality in male patients with chronic obstructive pul- monary disease [ J ]. Am J Respir Crit Care Med ,2002,166:680 - 685.
8Hanneke AH, Wijnboren Mlc, Didi M, et al. Determinants of different di - mensions of dis- ease severity in asthma and COPD [ J ]. Chest, 2001,199 : 1034 - 1042.

二级参考文献14

1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量：279
2[1]Jone PW,Quirk FH,Baveystock CM,et al.The St George′s Respiratory Questionnaire.Respir Med,1991;85:25～31
3[2]Anie KA,Jones PW,Hilton SR,et al.A computer-assisted telephone in-terview technique for assessment of asthma morbidity and drug use in adult asthma.J Clin Epidemiol,1996;49: 653～656
4[3]Quirk FH,Baveystock CM,Wilson R,et al.Influence of demogr-aphic and disease related factors on the degree of distress associated with symptoms and restrictions on daily living due to asthma in six countries.Eur Respir J,1991;4:167～171
5[4]The Netherlands Cancer Institute.Assessing health status and quality of life instruments: attributes and review criteria.Qual Life Res,2002;11:193～205
6[5]Almagro P,Calbo E,Ochoa de Echaguen A,et al.Mortality after hosp-italization for COPD.Chest,2002;121:1441～1448
7[6]Domingo-Salvany A,Lamarca R,Ferrer M,et al.Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2002;166:680～685
8[7]Hanneke AH,Wijnboren Mlc,Didi M,et al.Determinants of different dimensions of disease severity in asthma and COPD.Chest,2001; 199:1034～1042
9GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
10Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.